General Hospital (GH) in Ernakulam prepares for first heart transplant surgery in May, following successful cardiac care initiatives.

Canaccord analyst William Plovanic raised the firm’s price target on Edwards Lifesciences (EW) to $75 from $71. The firm said Edwards delivered ...

Heatwaves can get particularly distressing for people who have pre-existing heart conditions. The key lies in staying hydrated and avoiding long hours in the sun.

Edwards stock shot higher Thursday after the medtech player said tariffs are likely to have little impact in 2025.

Edwards Lifesciences raised 2025 revenue forecast after Q1 results beat EPS estimates and TMTT sales jumped 58% amid strong ...

Irvine-based medical device maker Edwards Lifesciences Corp. are up following yesterday's first quarter earnings.

The heart valve specialist saw better-than-expected TAVR sales in the first quarter as hospitals addressed capacity ...

Mark Wilterding; Mark Wilterding Senior Vice President, Investor Relations and Treasurer; Edwards Lifesciences Corp. Bernard Zovighian; President, Chief Executive Of ...

Piper Sandler upgraded Edwards Lifesciences (EW) to Overweight from Neutral with a price target of $80, up from $73. The firm sees a “better ...

Edwards Lifesciences Corp (EW) reports an 8% increase in total sales, raises full-year guidance, and achieves significant ...

Edwards Lifesciences reports 8% Q1 2025 sales growth to $1.41B, driven by TAVR & TMTT. Discover regulatory catalysts & future growth insights.

Edwards Lifesciences Corporation ( NYSE: EW) Q1 2025 Earnings Conference Call April 23, 2025 5:00 PM ET Mark Wilterding - SVP, Global Finance Bernard Zovighian - CEO Scott Ullem - CFO Daveen Chopra - ...